Link Cell Therapies: Funding, Investors & Team (Oct 2026)
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based treatments for cancer. The company applies proprietary logic-gating methods that require co-expression of multiple cancer antigens to activate therapeutic T cells, aiming to focus immune cell activity on tumor cells while reducing effects on non-cancerous tissues. Its work spans programs for solid tumors and certain hematologic cancers, with lead candidates progressing through preclinical development and preparation for clinical research. Link Cell Therapies also explores additional platforms and therapeutic programs that build on its core targeting technology to expand applications of engineered cellular therapies.
Link Cell Therapies has raised $60.0M across 1 funding round on record, the most recent a Series A of $60.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Link Cell Therapies Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Link Cell Therapies Funding Rounds
Link Cell Therapies Founders and Leadership Team
Contact details for the Link Cell Therapies team: 1 of 1 has an email address on file.
Start 14-day free trial →Link Cell Therapies Funding Compared to Other Biotechnology Startups
Link Cell Therapies' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Link Cell Therapies in Biotechnology and San Francisco
Companies Similar to Link Cell Therapies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Link Cell Therapies Funding FAQs
What does Link Cell Therapies do?
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based treatments for cancer. The company applies proprietary logic-gating methods that require co-expression of multiple cancer antigens to activate therapeutic T cells, aiming to focus immune cell activity on tumor cells while reducing effects on non-cancerous tissues. Its work spans programs for solid tumors and certain hematologic cancers, with lead candidates progressing through preclinical development and preparation for clinical research. Link Cell Therapies also explores additional platforms and therapeutic programs that build on its core targeting technology to expand applications of engineered cellular therapies.
How much funding has Link Cell Therapies raised?
Link Cell Therapies has raised $60.0M across 1 round on record. The most recent is a Series A of $60.0M announced in Dec 2025.
When did Link Cell Therapies last raise funding?
Link Cell Therapies' most recent funding round on record is a Series A of $60.0M, announced in Dec 2025.
Who founded Link Cell Therapies?
FundedIQ lists Robbie Majzner (Founder) at Link Cell Therapies.
Where is Link Cell Therapies headquartered?
Link Cell Therapies is based in San Francisco, California, United States.
How many employees does Link Cell Therapies have?
Link Cell Therapies is in the 11-50 employee band.
How does Link Cell Therapies' funding compare to other Biotechnology startups?
Link Cell Therapies' latest round of $60.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Link Cell Therapies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Link Cell Therapies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.